Skip to main content
Signal8

Selhorn Ryan J

SEC insider (Form 3/4/5 filer). CIK 0001670673. Chief Financial Officer at AYTU BIOPHARMA, INC (AYTU). 5 reported Form 4/5 transactions since Sep 2024; latest on Jul 28, 2026. Located in DENVER, CO.

Companies Selhorn Ryan J has filed insider reports for

  • AYTU BIOPHARMA, INC (AYTU): Officer, Chief Financial Officer
Selhorn Ryan J profile photo

Selhorn Ryan J

CIK: 0001670673

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (20.0%)

Derivative conversions

Awards (A)4 (80.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AYTU BIOPHARMA, INC logo
AYTU

AYTU BIOPHARMA, INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • AYTU BIOPHARMA, INC logo
    AYTU

    AYTU BIOPHARMA, INC

    Jul 28, 2026
    Award
    Direct
    25K shares-
  • AYTU BIOPHARMA, INC logo
    AYTU

    AYTU BIOPHARMA, INC

    Oct 3, 2025
    Award
    Direct
    16.2K shares-
  • AYTU BIOPHARMA, INC logo
    AYTU

    AYTU BIOPHARMA, INC

    Oct 3, 2025
    Award
    Direct
    17.5K shares-
  • AYTU BIOPHARMA, INC logo
    AYTU

    AYTU BIOPHARMA, INC

    Feb 5, 2025
    Exercise
    Direct
    105 shares-
  • AYTU BIOPHARMA, INC logo
    AYTU

    AYTU BIOPHARMA, INC

    Nov 11, 2024
    Award
    Direct
    14K shares-

1-5 of 5